Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurophysiology of lower urinary tract function and dysfunction.

Naoki Yoshimura, Michael B Chancellor

    Reviews in Urology
    |September 21, 2006
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The genitourinary phenotype of COVID: a personal perspective.

    International urology and nephrology·2026
    Same author

    Senescence-Driven Inflammation and Immune Dynamics in the Progression of Radiation Cystitis.

    Cells·2026
    Same author

    Safety and Efficacy of LP-10 Liposomal Tacrolimus in Oral Lichen Planus: A Multicenter Phase 2 Trial.

    Dermatology and therapy·2025
    Same author

    Advancing Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Diagnosis: A Comparative Analysis of Machine Learning Methodologies.

    Diagnostics (Basel, Switzerland)·2024
    Same author

    Rationale for the Use of Topical Calcineurin Inhibitors in the Management of Oral Lichen Planus and Mucosal Inflammatory Diseases.

    Cureus·2024
    Same author

    Iltamiocel Autologous Cell Therapy for the Treatment of Female Stress Urinary Incontinence: A Double-Blind, Randomized, Stratified, Placebo-Controlled Trial.

    Neurourology and urodynamics·2024
    Same journal

    Erratum: Author's Name Correction for "From Radical to Partial Nephrectomy in the Setting of Solitary Functioning Kidney: Neoadjuvant Treatment of Renal Cell Carcinoma".

    Reviews in urology·2021
    Same journal

    Update in Female Hormonal Therapy: What the Urologist Should Know: NYU Case of the Month, December 2020.

    Reviews in urology·2021
    Same journal

    Genetic Mutations Associated With Prostate Cancer and Normal Serum PSA and DRE-Implications for Prostate Cancer Screening and Management: NYU Case of the Month, November 2020.

    Reviews in urology·2021
    Same journal

    Surgical Management of the "Large" Prostate: The Robotic Simple Prostatectomy: NYU Case of the Month, October 2020.

    Reviews in urology·2021
    Same journal

    Cryptozoospermia Associated With Genital Tucking Behavior in a Transwoman.

    Reviews in urology·2021
    Same journal

    Washington Roundup.

    Reviews in urology·2021
    See all related articles

    As populations age, bladder control issues increase. This review explores bladder and urethral neurophysiology and pathophysiology to guide new drug therapies for better patient outcomes.

    Area of Science:

    • Urology
    • Neuroscience
    • Pharmacology

    Background:

    • The global population is aging, leading to a rise in bladder control dysfunctions.
    • Urinary incontinence and related conditions pose significant health challenges.
    • Existing treatments may not fully address the needs of all patients.

    Purpose of the Study:

    • To review the neurophysiology and pathophysiology of bladder and urethral function.
    • To discuss conceptual frameworks for developing novel pharmacological interventions.
    • To address the growing need for effective treatments for bladder control problems in an aging demographic.

    Main Methods:

    • Literature review of neurophysiological mechanisms.
    • Analysis of pathophysiological pathways in bladder dysfunction.

    Related Experiment Videos

  • Conceptual synthesis of drug development strategies.

    • Main Results:

    • Detailed overview of the neural control of micturition.
    • Explanation of common pathophysiological changes affecting bladder and urethral function.
    • Identification of potential therapeutic targets for drug development.

    Conclusions:

    • Understanding neurophysiology and pathophysiology is crucial for advancing bladder control therapies.
    • Novel drug development requires a targeted approach based on underlying mechanisms.
    • Improved pharmacological treatments are needed to manage the increasing prevalence of bladder control issues.